US Approves First Blood Test for Alzheimer’s: A Milestone in Early Detection
In a historic step to revolutionize the practice of neurological medicine, the US Food and Drug Administration has approved the commercial use of the first blood test for aiding the diagnosis of Alzheimer’s disease. The test is the Lumipulse G β-Amyloid Ratio (1-42/1-40) test and will allow doctors to have a useful tool to screen […]
US Approves First Blood Test for Alzheimer’s: A Milestone in Early Detection Read More »
In a historic step to revolutionize the practice of neurological medicine, the US Food and Drug Administration has approved the commercial use of the first blood test for aiding the diagnosis of Alzheimer’s disease. The test is the Lumipulse G β-Amyloid Ratio (1-42/1-40) test and will allow doctors to have a useful tool to screen